Acro Biomedical Co., Ltd. (ACBM)

Name: Acro Biomedical Co., Ltd. (ACBM) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name ACRO BIOMEDICAL CO., LTD. · CIK 0001622996 · OTC · Services-Amusement & Recreation Services

Sector Services
Incorporated NV
Fiscal year ends around Dec 31

For the year ended 2025-12-31, Acro Biomedical Co., Ltd. reported revenue of $0. Over the twelve months to 2026-06-30, revenue was $0.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-02

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2019-09-30	2018-12-31	2018-09-30
Revenue	$0	$0	$0	$0	$658.5K	$1.20M	$688.0K	$193.5K	n/a	n/a	$8.01M
Cost of Revenue	n/a	n/a	n/a	$0	$518.0K	$938.0K	$528.6K	$181.4K	n/a	n/a	$7.18M
Gross Profit	n/a	n/a	n/a	$0	$140.5K	$259.5K	$159.4K	$12.1K	n/a	n/a	$833.4K
R&D Expense	n/a	n/a	$0	$4.79M	$10.08M	$5.29M	n/a	n/a	n/a	n/a	n/a
Operating Income	-$209.3K	-$154.0K	-$38.0K	-$8.80M	-$15.87M	-$7.69M	-$130.5K	-$422.8K	n/a	n/a	$515.5K
Net Income	-$140.4K	-$101.1K	-$42.3K	-$8.81M	-$15.87M	-$7.70M	-$117.5K	-$371.6K	n/a	n/a	$419.7K
EPS (Diluted)	n/a	$0.00	$0.00	-$0.15	-$0.26	n/a	n/a	n/a	n/a	n/a	n/a
Total Assets	$3.6K	$14.1K	$32.0K	$58.5K	$687.5K	$761.1K	$998.1K	$932.1K	$1.07M	n/a	$1.48M
Total Liabilities	n/a	n/a	$326.9K	$315.5K	$201.1K	$117.4K	$312.2K	$133.9K	$195.8K	n/a	$240.7K
Shareholders' Equity	-$444.8K	-$387.0K	-$295.0K	-$257.0K	$486.4K	$643.7K	$685.9K	$798.2K	$873.7K	$1.17M	$1.24M
Cash & Equivalents	n/a	n/a	n/a	n/a	n/a	n/a	$18.1K	$911	$1.5K	$37.6K	$1.1K
Operating Cash Flow	-$140.1K	-$196.3K	-$36.7K	-$15.4K	-$147.5K	$299.3K	-$199.5K	-$59.7K	n/a	n/a	-$140.4K
Shares Outstanding	60.04M	60.04M	60.04M	60.04M	60.04M	60.04M	47.76M	47.76M	47.76M	n/a	47.76M
Weighted Average Diluted Shares	n/a	60.04M	60.04M	60.04M	60.04M	53.84M	47.76M	n/a	n/a	n/a	n/a
EPS (Basic)	n/a	n/a	n/a	n/a	n/a	-$0.14	$0.00	n/a	n/a	n/a	n/a